Free tool
Healthcare stocks
We cover 1,667 companies in the Healthcare sector. The median market value in the group is $302.36M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is −0.18%. 50% of the 967 with a 200-day average trade above it. Price change over the past year runs from −47.3% to +123.5% across the middle 80 percent of the group, with a median of +2.0%. Among those 1,000, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,667 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| CLGN | CollPlant Biotechnologies Ltd. | $0.31 | −6.25% | −79.22% | −89.43% |
| PMCB | PharmaCyte Biotech, Inc. | $0.54 | −8.39% | −26.76% | −44.28% |
| ECS.AX | ECS Botanics Holdings Ltd | 0.01 AUD | −16.67% | −16.67% | −33.33% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.93 | +23.72% | −32.04% | −48.46% |
| ALPAT.PA | Plant Advanced Technologies SA | 4.20 EUR | 0.00% | −48.91% | −53.33% |
| ERNA | Ernexa Therapeutics Inc. | $4.89 | +35.46% | −83.14% | −85.93% |
| BRTX | BioRestorative Therapies, Inc. | $0.22 | −18.64% | −82.22% | −86.10% |
| BGT.AX | Bio-Gene Technology Limited | 0.02 AUD | −5.26% | −28.00% | −21.74% |
| QLIFE.ST | Qlife Holding AB (publ) | 1.81 SEK | −6.91% | −30.80% | −52.47% |
| PULM | Pulmatrix, Inc. | $1.53 | −9.23% | −32.52% | −68.62% |
| NEOLA.ST | Neola Medical AB (publ) | 0.49 SEK | −17.67% | −54.05% | −79.24% |
| TCF.L | Theracryf Plc | 0.19 GBP | −2.56% | −5.00% | −20.83% |
| REDS.ST | Redsense Medical AB (publ) | 3.23 SEK | −19.05% | −24.71% | −39.96% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +66.67% | −47.37% | −54.55% |
| POAS | Phaos Technology Holdings (Caym | $0.17 | −21.64% | −94.54% | −95.52% |
| WOK | WORK Medical Technology Group LTD | $2.25 | +22.28% | −3.02% | −99.97% |
| LABT | Lakewood-Amedex Biotherapeutics, Inc. | $2.45 | +16.67% | −71.68% | −71.68% |
| ALSPW.PA | Spineway SA | 0.13 EUR | −1.90% | −12.99% | +3.24% |
| SUN.L | Surgical Innovations Group plc | 0.43 GBP | −15.00% | −5.56% | −39.29% |
| ADXN | Addex Therapeutics Ltd | $4.23 | −28.12% | −47.71% | −46.46% |
| BIOSGN.ST | Biosergen AB (publ) | 2.48 SEK | +262.31% | −93.80% | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | 2.20 SEK | −5.17% | −48.36% | +39.24% |
| CSCI.TO | COSCIENS Biopharma Inc. | 7.30 CAD | −7.59% | +151.72% | +60.79% |
| SDOS.ST | ScandiDos AB (publ) | 0.86 SEK | +3.61% | −25.22% | −34.85% |
| BMRA | Biomerica, Inc. | $1.69 | +5.62% | −33.21% | −46.35% |
| BCAB | BioAtla, Inc. | $3.12 | −11.61% | −88.31% | −86.04% |
| SERV.ST | Servana AB | 0.01 SEK | −16.22% | +210.00% | +106.67% |
| VVOS | Vivos Therapeutics, Inc. | $0.25 | −39.57% | −89.97% | −94.48% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| FLUI.ST | Fluicell AB (publ) | 34.60 SEK | +14.57% | +246.00% | +247.74% |
| HCWB | HCW Biologics Inc. | $2.70 | +4.45% | +141.07% | −55.15% |
| ZCMD | Zhongchao Inc. | $0.81 | −31.17% | −79.16% | −89.73% |
| MLEC | Moolec Science SA | $7.18 | −1.17% | +73.43% | −63.74% |
| ELAB | PMGC Holdings Inc. | $6.05 | +539.53% | −82.25% | −96.39% |
| XAIR | Beyond Air, Inc. | $4.97 | −8.97% | +529.91% | +117.98% |
| VNRX | VolitionRx Limited | $0.34 | −60.09% | −93.72% | −97.47% |
| SBFM | Sunshine Biopharma, Inc. | $1.24 | −13.29% | −3.13% | −16.22% |
| CVKD | Cadrenal Therapeutics, Inc. | $1.55 | −22.89% | −78.85% | −88.87% |
| JAGX | Jaguar Health, Inc. | $0.92 | −4.63% | −97.37% | −98.52% |
| KONT.ST | Kontigo Care AB (publ) | 1.33 SEK | −8.62% | −26.39% | −42.39% |
| TCRT | Alaunos Therapeutics, Inc. | $1.78 | −6.52% | −45.85% | −6.03% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.33 | +710.86% | +426.12% | +211.51% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
| SILO | Silo Pharma, Inc. | $2.50 | −43.95% | +644.05% | +290.62% |
| APVO | Aptevo Therapeutics Inc. | $2.41 | −42.76% | −74.33% | −92.52% |
| ALBLU.PA | Bluelinea Société Anonyme | 0.17 EUR | −23.18% | −65.79% | −68.11% |
| GRI | GRI Bio, Inc. | $1.91 | +33.57% | −75.64% | −95.23% |
| AINO.ST | Aino Health AB (publ) | 0.20 SEK | +2.06% | +3.66% | −10.81% |
| MBIO | Mustang Bio, Inc. | $0.56 | −11.25% | −47.66% | −63.40% |
| ACR.AX | Acrux Limited | 0.01 AUD | −9.09% | −33.33% | −33.33% |
| FEED | ENvue Medical, Inc. | $0.38 | +10.20% | −84.57% | −93.51% |
| ISPC | iSpecimen Inc. | $1.64 | −13.23% | −85.66% | −94.46% |
| OSRH | OSR Health, Inc. | $0.17 | −63.24% | −71.48% | −80.93% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| XRTX | XORTX Therapeutics Inc. | $2.22 | +8.20% | −22.18% | −43.99% |
| BIT.AX | Biotron Limited | 0.00 AUD | −20.00% | −42.86% | −50.00% |
| ADR.AX | Adherium Limited | 0.10 AUD | −4.76% | +1900.00% | +1900.00% |
| VIVS | VivoSim Labs, Inc. | $0.29 | −23.42% | −84.52% | −84.18% |
| CRIS | Curis, Inc. | $1.54 | −68.12% | +57.14% | −5.52% |
| TRP.AX | Tissue Repair Ltd | 0.09 AUD | +4.76% | −77.44% | −70.67% |
| REVB | Revelation Biosciences, Inc. | $0.96 | −8.00% | −70.63% | −91.25% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $1.08 | −28.00% | −47.67% | −78.23% |
| RDHL | RedHill Biopharma Ltd. | $0.62 | −15.71% | −40.26% | −53.74% |
| INDCT.OL | Induct AS | 0.77 NOK | −12.47% | −83.00% | −78.07% |
| CAN.AX | Cann Group Limited | 0.00 AUD | 0.00% | −66.67% | −75.00% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | 0.16 SEK | +30.42% | +16.79% | +11.79% |
| UPC | Universe Pharmaceuticals INC | $5.32 | +66.77% | +27.88% | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.35 | −21.14% | +14.41% | −19.16% |
| TNON | Tenon Medical, Inc. | $5.21 | +2642.11% | +434.91% | +297.71% |
| PMED.ST | PEPTONIC medical AB (publ) | 0.00 SEK | +20.00% | −25.00% | −25.00% |
| NXGL | NEXGEL, Inc. | $0.36 | −19.09% | −80.33% | −84.79% |
| VFX.AX | VISIONFLEX FPO [VFX] | 0.06 AUD | −5.17% | −42.11% | −56.00% |
| GCTK | GlucoTrack, Inc. | $0.32 | +7.03% | −91.72% | −92.77% |
| HIQ.AX | HITIQ Limited | 0.01 AUD | −16.67% | −76.19% | −72.22% |
| GOVX | GeoVax Labs, Inc. | $0.63 | −13.33% | −87.82% | −96.67% |
| ARTL | Artelo Biosciences, Inc. | $0.71 | −19.25% | −81.35% | −97.37% |
| GNPX | Genprex, Inc. | $3.97 | −50.56% | +121.79% | −54.10% |
| NUWE | Nuwellis, Inc. | $1.01 | −47.67% | −44.20% | −80.39% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% |
| PYC.L | Physiomics Plc | 0.52 GBP | +7.29% | +80.70% | +21.18% |
| FUM.L | Futura Medical plc | 0.39 GBP | −2.26% | −68.29% | −95.67% |
| MONSO.CO | Monsenso A/S | 0.26 DKK | −19.25% | +73.33% | +23.81% |
| SPERM.ST | Spermosens AB (publ) | 0.01 SEK | −10.20% | +57.14% | +15.79% |
| GUARD.ST | Disruptive Pharma AB (publ) | 1.47 SEK | −10.49% | +1.94% | −93.53% |
| NIVF | NewGenIvf Group Limited | $0.47 | −48.94% | −94.09% | −99.58% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
| PRFX | PRF Technologies Ltd. | $0.98 | −8.68% | −72.04% | −87.86% |
| TD1.AX | TALi Digital Limited | 0.09 AUD | +11.11% | +73.08% | −10.00% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| MTNB | Matinas BioPharma Holdings, Inc. | $0.20 | −32.97% | −68.32% | −90.08% |
| RGT.AX | Argent BioPharma Limited | 0.04 AUD | −36.36% | −50.00% | −74.07% |
| IVX.AX | Invion Limited | 0.04 AUD | −18.18% | −61.29% | −72.31% |
| PPBT | Purple Biotech Ltd | $1.73 | +26.28% | −73.79% | −92.21% |
| PROGEN.ST | Prostatype Genomics AB (publ) | 0.16 SEK | −4.59% | −59.48% | −79.42% |
| NOTV | Inotiv Inc | $0.01 | 0.00% | −97.94% | −99.37% |
| VAL.L | ValiRx plc | 0.16 GBP | +3.33% | −57.53% | −73.04% |
| PERP-B.ST | Perpetua Medical AB (publ) | 3.04 SEK | −18.50% | −41.54% | −35.32% |
| AKAN | Akanda Corp. | $4.24 | −31.61% | −61.81% | −95.20% |
| IVF | INVO Fertility, Inc. | $1.06 | +8.16% | −76.44% | −97.38% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | 0.97 SEK | +1.58% | −13.06% | −59.79% |
| ADTX | Aditxt, Inc. | $0.00 | −48.00% | −100.00% | −100.00% |
| GLH.AX | Global Health Limited | 0.06 AUD | −6.15% | −29.89% | −33.70% |
| PFSA | Profusa, Inc. | $4.26 | +309.13% | −43.27% | −86.13% |
| SPEC.ST | SpectraCure AB (publ) | 0.03 SEK | −3.33% | −79.63% | −81.77% |
| CMND | Clearmind Medicine Inc. | $1.72 | +17.81% | −91.36% | −99.58% |
| ONCO | Onconetix, Inc. | $0.64 | −22.77% | −99.20% | −99.56% |
| RNAZ | TransCode Therapeutics, Inc. | $2.34 | −53.20% | −68.38% | −76.72% |
| PPCB | Propanc Biopharma, Inc. | $1.07 | −11.57% | −92.51% | −98.54% |
| OGEN | Oragenics, Inc. | $0.53 | +6.00% | −36.90% | −51.82% |
| IBAI.L | Imaging Biometrics Ltd. | 0.64 GBP | +5.83% | −25.29% | +2.42% |
| POLAR.ST | PolarCool AB (publ) | 1.73 SEK | +8.12% | −55.87% | −67.96% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +10.00% | +6.94% | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.70 SEK | +16.33% | −27.14% | −58.08% |
| VRAX | Virax Biolabs Group Limited | $2.77 | −4.15% | +621.35% | +365.55% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $3.59 | +28.67% | +98.34% | +7.65% |
| EXL.AX | Elixinol Wellness Limited | 0.01 AUD | 0.00% | −22.22% | −58.82% |
| ANR.AX | Anatara Lifesciences Ltd | 0.01 AUD | −10.00% | −35.71% | 0.00% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| OSX.AX | Osteopore Limited | 0.00 AUD | 0.00% | −38.46% | −60.00% |
| SLXN | Silexion Therapeutics Corp | $0.35 | −85.51% | −81.12% | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $3.01 | −25.50% | −61.53% | −95.78% |
| CYP.AX | Cynata Therapeutics Limited | 0.01 AUD | −8.33% | −96.90% | −94.50% |
| MNDR | Mobile-health Network Solutions | $1.64 | −1.80% | +72.63% | −69.91% |
| ADV.WA | Adiuvo Investments S.A. | 0.53 PLN | +13.49% | −7.34% | −34.08% |
| SXTC | China SXT Pharmaceuticals, Inc. | $3.56 | +6037.93% | −98.64% | −98.40% |
| RESP.ST | Respiratorius AB (publ) | 2.28 SEK | +3.17% | +31.03% | −39.20% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +6.95% | −69.51% | −22.48% |
| 27N0.DE | Cannovum Cannabis AG | 0.56 EUR | +10.76% | +24.94% | +22.47% |
| BBLG | Bone Biologics Corporation | $0.62 | −35.90% | −60.00% | −71.35% |
| BP8.AX | BPH Global Ltd | 0.00 AUD | −25.00% | −25.00% | −25.00% |
| AEMD | Aethlon Medical, Inc. | $2.28 | +307.14% | −19.15% | −85.66% |
| VSEE | VSee Health, Inc. | $0.03 | −72.64% | −93.13% | −96.63% |
| BIG1.DE | Bio-Gate AG | 2.83 EUR | −14.39% | +262.18% | +200.53% |
| APTA.ST | Aptahem AB (publ) | 0.56 SEK | −15.96% | −51.69% | −67.65% |
| SNYR | Synergy CHC Corp. | $0.10 | −42.69% | −94.79% | −95.31% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
| MONI.ST | Monivent AB | 0.17 SEK | −5.71% | −49.39% | −37.02% |
| APLI.TO | Appili Therapeutics Inc. | 0.02 CAD | +50.00% | −40.00% | −25.00% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −3.51% | −57.96% | −72.03% |
| CHLL.L | Chill Brands Group PLC | 2.00 GBP | −9.09% | −74.19% | −87.88% |
| OAK.AX | Oakridge International Limited | 0.06 AUD | −25.00% | −20.00% | −26.83% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| ODIN.ST | Odinwell AB (publ) | 0.14 SEK | −25.80% | −50.71% | −61.25% |
| BDRX | Biodexa Pharmaceuticals Plc | $0.98 | −32.13% | −92.05% | −96.58% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −42.86% | −88.33% | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −25.93% | −97.66% | −98.15% |
| RDGT | Ridgetech, Inc. | $1.03 | −11.21% | −99.74% | −99.43% |
| BJDX | Bluejay Diagnostics, Inc. | $0.89 | −10.66% | −65.90% | −83.70% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | 0.14 SEK | −35.19% | −70.34% | −73.58% |
| VTAK | Catheter Precision, Inc. | $0.21 | −25.36% | −89.60% | −91.47% |
| TRLS.L | Trellus Health plc | 0.04 GBP | +3233.33% | −90.00% | −94.29% |
| VBIO | Valion Bio, Inc. | $0.16 | −45.83% | −89.01% | −94.92% |
| VERO | Venus Concept Inc. | $0.31 | — | −79.54% | −90.22% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
| S2M.ST | S2Medical AB (publ) | 0.00 SEK | −11.11% | −52.00% | −63.08% |
| CHM.AX | Chimeric Therapeutics Limited | 0.01 AUD | −76.74% | −95.00% | −96.67% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | 0.47 SEK | +16.75% | −41.99% | −72.69% |
| ALSAF.PA | Safe Orthopaedics SA | 0.64 EUR | 0.00% | −61.90% | −73.33% |
| SDET.ST | SensoDetect Aktiebolag (publ) | 0.00 SEK | −27.27% | −97.75% | −99.53% |
| IMCC | IM Cannabis Corp. | $0.11 | +2.20% | −92.52% | −95.07% |
| EPI.AX | EPIMINDER FPO [EPI] | 0.36 AUD | +29.09% | −65.53% | −72.90% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.